The immune therapy program will make cutting edge contributions to the field of immune-oncology by uncovering novel findings in basic and translational research, as well as learning from patient responses in clinical trials to improve response rates and quality of life. Our goal is also to develop novel technologies and reagents to remain at the forefront of this field.


Scientist, Senior Scientist, Clinician Scientist

Hirano, Naoto (Chair)

Brooks, David

Mak, Tak W

McGaha, Tracy

Ohashi, Pamela

Reedijk, Michael


Affiliate Scientist 

Sacher, Adrian


Emeritus Scientist 

Paige, Christopher


Staff Scientist 

Nguyen, Linh


Clinical Champion

Gerbitz, Armin

Saibil, Sam